[1]
2026. Efficacy and safety of bulevirtide in patients with chronic hepatitis D treated under early access in Switzerland: a retrospective analysis. Swiss Medical Weekly. 156, 2 (Feb. 2026), 4736. DOI:https://doi.org/10.57187/4736.